Behaviour of four different B16 murine melanoma cell sublines: C57BL/6J skin

Transplantable murine melanomas are well‐established models for the study of experimental cancer therapies. The aim of this study was to explore the behaviour of four different B16 murine melanoma cell sublines after inoculation into C57BL/6J mice; and, more specifically to analyse skin changes, with respect to two specific parameters: clinical (tumour volume, melanin amount, erythema) and histological (H & E, S100, VEGF expression). Both non‐invasive and invasive analysis showed that B164A5 is the most aggressive melanoma cell line for C57BL/6J's skin, followed by B16F10 and then by diminished aggressive growth pattern by the B16GMCSF and B16FLT3 cell lines.

[1]  Lawrence E Gibson,et al.  Increasing incidence of melanoma among young adults: an epidemiological study in Olmsted County, Minnesota. , 2012, Mayo Clinic proceedings.

[2]  J. Galipeau,et al.  Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 Fusion cDNA for Cancer Gene Immunotherapy , 2004, Cancer Research.

[3]  I. Fidler.  The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. , 1973, European journal of cancer.

[4]  M. Tichý,et al.  The role of vascular endothelial growth factors and their receptors in malignant melanomas. , 2008, Neoplasma.

[5]  M. Brites,et al.  Epidemiology of basal cell carcinomas and squamous cell carcinomas in a Department of Dermatology: a 5 year review. , 2012, Anais brasileiros de dermatologia.

[6]  S. Saraf,et al.  SKIN CARE ASSESSMENT ON THE BASIS OF SKIN HYDRATION , MELANIN , ERYTHEMA AND SEBUM AT VARIOUS BODY , 2011 .

[7]  I. Zupkó,et al.  Effect of the Isoflavone Genistein on Tumor Size, Metastasis Potential and Melanization in a B16 Mouse Model of Murine Melanoma , 2013, Natural product communications.

[8]  Michael R Hamblin,et al.  Ultraviolet Radiation in Wound Care: Sterilization and Stimulation. , 2013, Advances in wound care.

[9]  L. Wen,et al.  Anticancer effect of realgar nanoparticles on mouse melanoma skin cancer in vivo via transdermal drug delivery , 2010, Medical oncology.

[10]  N. Restifo,et al.  B16 as a Mouse Model for Human Melanoma , 2000, Current protocols in immunology.

[11]  J. Allison,et al.  Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumors. , 2009, Cancer research.

[12]  Delong Liu,et al.  Current management and novel agents for malignant melanoma , 2012, Journal of Hematology & Oncology.

[13]  Bart Landuyt,et al.  Vascular Endothelial Growth Factor and Angiogenesis , 2004, Pharmacological Reviews.

[14]  H. Joller-jemelka,et al.  Serum S100--a marker for disease monitoring in metastatic melanoma. , 1997, Dermatology.

[15]  A. Bode,et al.  Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth , 2013, Cancer Prevention Research.

[16]  B. Liagre,et al.  A novel form of melanoma apoptosis resistance: melanogenesis up-regulation in apoptotic B16-F0 cells delays ursolic acid-triggered cell death. , 2011, Experimental cell research.

[17]  R. Wolfe,et al.  Characteristics and associations of high-mitotic-rate melanoma. , 2014, JAMA dermatology.

[18]  P. Vargas,et al.  Immunization with antigen-pulsed dendritic cells significantly improves the immune response to weak self-antigens. , 2006, Immunobiology.

[19]  Rong-cheng Luo,et al.  GM-CSF-surface-modified B16.F10 melanoma cell vaccine. , 2006, Vaccine.

[20]  K. Jooss,et al.  Vascular Endothelial Growth Factor Blockade Reduces Intratumoral Regulatory T Cells and Enhances the Efficacy of a GM-CSF–Secreting Cancer Immunotherapy , 2006, Clinical Cancer Research.

[21]  R. Thurman,et al.  Dietary glycine inhibits the growth of B16 melanoma tumors in mice. , 1999, Carcinogenesis.

[22]  J. Schachter,et al.  Differences in cytokine levels in melanoma patients with and without redness (Brenner sign). , 2009, Anticancer research.

[23]  R. Harpio,et al.  S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma. , 2004, Clinical biochemistry.

[24]  S. Florell,et al.  Melanocyte expression of survivin promotes development and metastasis of UV-induced melanoma in HGF-transgenic mice. , 2007, Cancer research.

[25]  Rory Wolfe,et al.  Rate of growth in melanomas: characteristics and associations of rapidly growing melanomas. , 2006, Archives of dermatology.

[26]  B. Teicher.  Tumor Models in Cancer Research , 2001, Cancer Drug Discovery and Development.

[27]  R. Kumar,et al.  GM‐CSF‐transduced B16 melanoma cells are highly susceptible to lysis by normal murine macrophages and poorly tumorigenic in immune‐compromised mice , 1999, Journal of leukocyte biology.

[28]  E F TRAUB,et al.  Cancer of skin. , 1954, Bulletin. New York Medical College.

[29]  H. Matsui,et al.  The transdermal inhibition of melanogenesis by a cell-membrane-permeable peptide delivery system based on poly-arginine. , 2014, Biomaterials.

[30]  M. Matsuda,et al.  Suppression of Melanin Production by Expression of HSP70* , 2010, The Journal of Biological Chemistry.

[31]  D. Maria,et al.  Prognostic relationship of metabolic profile obtained of melanoma B16F10. , 2013, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[32]  H. Isoda,et al.  Lupenone from Erica multiflora Leaf Extract Stimulates Melanogenesis in B16 Murine Melanoma Cells through the Inhibition of ERK1/2 Activation , 2013, Planta Medica.

[33]  D N Slatkin,et al.  Melanin content of hamster tissues, human tissues, and various melanomas. , 1981, Cancer research.

[34]  G. Dranoff,et al.  Role of GM-CSF signaling in cell-based tumor immunization. , 2009, Blood.

[35]  J. Vostálová,et al.  Ultraviolet light induced alteration to the skin. , 2006, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[36]  I. Fidler,et al.  Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice. , 1986, Cancer research.

[37]  R. Ambrus,et al.  Betulin Complex in γ-Cyclodextrin Derivatives: Properties and Antineoplasic Activities in In Vitro and In Vivo Tumor Models , 2012, International journal of molecular sciences.

[38]  P. Caspary,et al.  Variation of melanin levels in the skin in areas exposed and not exposed to the sun following winter and summer , 2014 .

[39]  Jeffrey E Gershenwald,et al.  Final version of 2009 AJCC melanoma staging and classification. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  A. Brożyna,et al.  Inhibition of melanogenesis as a radiation sensitizer for melanoma therapy , 2008, International journal of cancer.

[41]  L. Barbu-Tudoran,et al.  A characterization of four B16 murine melanoma cell sublines molecular fingerprint and proliferation behavior , 2013, Cancer Cell International.

[42]  E. Jaffee,et al.  Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.